Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. slides, 8-K earnings release, 10-Q stay in one workspace.
SMMT
$14.15
-6.14%
SMMT
· Summit Therapeutics Inc.
$14.15
-0.93 (-6.14%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Going-concern doubt
— cleared Nov 4, 2026
The latest filing no longer states the doubt (first flagged Jul 23, 2026).
View the 10-Q filed Nov 4, 2026Market Cap
$11.32B
Shares
799.76M
Volume · Nov 13
5.56M
Avg daily vol (3M)
6.24M
All webcasts
Earnings call · FY2026 Q1
Summit Therapeutics Inc. (SMMT) Q1 2026 Earnings Call
Diluted EPS
-$0.24
Net income
-$189.42M
Research coverage
3 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Apr 30, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Apr 30, 2026 · complete as-filed document